Identification of two rare and novel large deletions in ITGB4 gene causing epidermolysis bullosa with pyloric atresia

dc.contributor.authorMencía, A
dc.contributor.authorGarcía, M
dc.contributor.authorGarcía, E
dc.contributor.authorLlames, S
dc.contributor.authorCharlesworth, A
dc.contributor.authorde Lucas, R
dc.contributor.authorVicente, A
dc.contributor.authorTrujillo-Tiebas, MJ
dc.contributor.authorCoto, P
dc.contributor.authorCosta, M
dc.contributor.authorVera, A
dc.contributor.authorLópez-Pestaña, A
dc.contributor.authorMurillas, R
dc.contributor.authorMeneguzzi, G
dc.contributor.authorJorcano, JL
dc.contributor.authorConti, CJ
dc.contributor.authorEscámez-Toledano, MJ
dc.contributor.authordel Río, M
dc.date.accessioned2026-01-09T13:58:10Z
dc.date.available2026-01-09T13:58:10Z
dc.date.issued2016-04
dc.description.abstractEpidermolysis bullosa with pyloric atresia (EB-PA) is a rare autosomal recessive hereditary disease with a variable prognosis from lethal to very mild. EB-PA is classified into Simplex form (EBS-PA: OMIM #612138) and Junctional form (JEB-PA: OMIM #226730), and it is caused by mutations in ITGA6, ITGB4 and PLEC genes. We report the analysis of six patients with EB-PA, including two dizygotic twins. Skin immunofluorescence epitope mapping was performed followed by PCR and direct sequencing of the ITGB4 gene. Two of the patients presented with non-lethal EB-PA associated with missense ITGB4 gene mutations. For the other four, early postnatal demise was associated with complete lack of β4 integrin due to a variety of ITGB4 novel mutations (2 large deletions, 1 splice-site mutation and 3 missense mutations). One of the deletions spanned 278 bp, being one of the largest reported to date for this gene. Remarkably, we also found for the first time a founder effect for one novel mutation in the ITGB4 gene. We have identified 6 novel mutations in the ITGB4 gene to be added to the mutation database. Our results reveal genotype-phenotype correlations that contribute to the molecular understanding of this heterogeneous disease, a pivotal issue for prognosis and for the development of novel evidence-based therapeutic options for EB management.es_ES
dc.identifier.citationExp Dermatol. 2016 Apr;25(4):269-74.es_ES
dc.identifier.doi10.1111/exd.12938.
dc.identifier.urihttps://hdl.handle.net/20.500.14855/5451
dc.language.isoenges_ES
dc.publisherExp Dermatol.es_ES
dc.rights.accessRightsopen accesses_ES
dc.subjectITGB4 mutationes_ES
dc.subjectEpidermolysis bullosaes_ES
dc.subjectgenodermatoseses_ES
dc.subjectinherited skin diseaseses_ES
dc.subjectpyloric atresiaes_ES
dc.titleIdentification of two rare and novel large deletions in ITGB4 gene causing epidermolysis bullosa with pyloric atresiaes_ES
dc.typejournal articlees_ES
dc.type.hasVersionAMes_ES

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
9_Mencia_ExpDerm_2016.pdf
Size:
628.39 KB
Format:
Adobe Portable Document Format